Last reviewed · How we verify
NCT07084480
Giant Cell Arteritis - Ways to Precision Medicine
trial in Giant Cell Arteritis in 400 participants. Currently enrolling.
31 July 2030
Quick facts
| Lead sponsor | Wuerzburg University Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 14 November 2025 |
| Primary completion | 31 July 2030 |
| Estimated completion | 31 July 2033 |
| Sites | 1 location across Germany |
Conditions studied
- Giant Cell Arteritis — all drugs for Giant Cell Arteritis →
- Polymyalgia Rheumatic (PMR) — all drugs for Polymyalgia Rheumatic (PMR) →
Sponsor
Wuerzburg University Hospital
Who can join
18 and older, any sex, with Giant Cell Arteritis or Polymyalgia Rheumatic (PMR). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07084480
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Giant Cell Arteritis
Currently open trials in the same condition.
- NCT06894602 — Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis · recruiting
- NCT05935709 — DANIsh VASculitis Database (DANIVAS) · recruiting
- NCT06460142 — Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic · recruiting
- NCT06011512 — Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica. · recruiting
- NCT05904301 — Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases · recruiting
Other Wuerzburg University Hospital trials
Trials by the same sponsor.
- NCT07040189 — Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders · NA · not yet recruiting
- NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
- NCT07108569 — Ability of Physicians to Distinguish Real From Artificial Colon Polyp Images · NA · completed
- NCT06553326 — EndoStyle: Artificial Intelligence Image Transformation Tool for Colonoscopy · completed
- NCT06625268 — Rapid Point-of-care Bacteriuria and Microbial Susceptibility for Women With Suspected Uncomplicated Urinary Tract Infect · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07084480 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wuerzburg University Hospital
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07084480.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing